CVR - Coronavirus Vaccines R&D Roadmap

overhead image of group of people

The CVR Initiative

CIDRAP and CEPI address the threat of coronaviruses through a comprehensive and coordinated initiative to advance vaccine R&D
vaccine vials

Coronavirus Vaccine Technology Landscape

The Landscape compiles and summarizes publicly available information on the global R&D pipeline of broadly protective, MERS, and SARS-CoV-2 coronavirus vaccine candidates in preclinical and clinical development.

SARS CoV 2

CVR Scholar Hub

The CVR Scholar Hub makes available research that illuminates the virologic and immunologic underpinnings of coronavirus vaccinology, including information on mucosal vs. systemic immunity, broadly conserved epitopes, mucosal biomarkers, and more.

Covid-19

The CVR Initiative

A joint initiative of CIDRAP and CEPI that monitors and evaluates progress towards the development of coronavirus vaccines, creating open-access resources for researchers, developers, and funding organizations.

crowd of people

Roadmap Vision

The roadmap vision is one of accelerated development of durable, broadly protective coronavirus vaccines that will be suitable for use in all regions of the globe, reduce severe illness and death, and mitigate the impact of future coronavirus epidemics worldwide.

Funding for the CVR Initiative provided by
Funding for CVR development provided by

The findings and conclusions contained within are those of the authors and do not necessarily reflect the positions or policies of the Bill & Melinda Gates Foundation and The Rockefeller Foundation.